CME Group Inc. (NASDAQ:CME) Shares Sold by Kiely Wealth Advisory Group Inc.

Kiely Wealth Advisory Group Inc. lowered its stake in CME Group Inc. (NASDAQ:CME) by 6.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,400 shares of the financial services provider’s stock after selling 100 shares during the quarter. Kiely Wealth Advisory Group Inc.’s holdings in CME Group were worth $287,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in shares of CME Group by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock worth $7,044,821,000 after purchasing an additional 215,044 shares in the last quarter. Capital International Investors increased its stake in CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after buying an additional 3,069,806 shares in the last quarter. Capital World Investors raised its holdings in shares of CME Group by 8.7% during the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after acquiring an additional 1,172,575 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of CME Group by 2.9% in the first quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock valued at $1,462,678,000 after acquiring an additional 189,842 shares in the last quarter. Finally, Parnassus Investments LLC boosted its stake in shares of CME Group by 0.4% in the fourth quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock worth $1,193,551,000 after acquiring an additional 23,583 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. Piper Sandler reaffirmed an “overweight” rating and set a $225.00 target price on shares of CME Group in a research note on Tuesday, August 20th. Bank of America lowered shares of CME Group from a “neutral” rating to an “underperform” rating and lowered their price target for the stock from $212.00 to $177.00 in a research report on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft increased their price objective on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th. Keefe, Bruyette & Woods boosted their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Finally, JPMorgan Chase & Co. increased their price target on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $209.73.

CME Group Stock Down 0.7 %

Shares of NASDAQ CME opened at $213.16 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The business’s 50 day moving average is $207.86 and its two-hundred day moving average is $207.53. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $223.80. The firm has a market cap of $76.75 billion, a price-to-earnings ratio of 24.25, a PEG ratio of 8.85 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.30 EPS. Research analysts predict that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be issued a dividend of $1.15 per share. The ex-dividend date is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.16%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.